New physio device: Pheezee
Startoon Labs launched Pheezee, a US FDA–registered physiotherapy tracking device for upper and lower extremities, this week — a product aimed at tightening rehab metrics and remote adherence announced. It’s positioned for clinics wanting objective exercise tracking in sports-rehab programs.
Pheezee received US FDA 510(k)‑exempt clearance in May 2023 expresshealthcare.in, and the device is additionally registered with India’s Central Drugs Standard Control Organization (CDSCO) for domestic market access pharmabiz.com. The wearable captures surface electromyogram (sEMG) and joint range‑of‑motion (ROM) data simultaneously and produces instant clinician reports for session-level objective metrics ikpknowledgepark.com. Startoon Labs signed a memorandum of understanding with Medplus on April 4, 2025 to initiate Pheezee assessments across Medplus diagnostic centres as an initial deployment pathway expresshealthcare.in. Startoon Labs is Hyderabad‑based, led by founder‑CEO Suresh Susurla and holds ISO 13485:2016 and ISO 9001:2015 certifications clival.com; the company also received BIRAC–Biotech Ignition Grant (BIG) support with IKP as the BIG partner during product development ikpknowledgepark.com.
